Under the heavy pressure of a 200% drug tariff, Biogen (BIIB.US) added an additional $2 billion investment to expand its U.S. factory.

Zhtng cijng APP huzh, bi jin (BIIB.US) zhuy biosh, jing xing q wiy bi k lu li n zhu de xin yu gngchng yu tuz 20 y miyun. Cj zhzi kud q zi migu de yw, y y du migu zngtng dng n d tlng p de gunshu wixi. According to the Wise Finance APP, Biogen (BIIB.US) announced on Monday that it will invest an additional $2 billion in its existing factory in North Carolina. This move aims to expand its business in the United States in response to President Donald Trump's tariff threats.